Trabulus S, Altiparmak M, Apaydin S, Serdengecti K, Sariyar M (2008) Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol. In: Transplantation proceedings, Vol 1. Elsevier, pp 160–166

Bouquegneau A, Salam S, Delanaye P, Eastell R, Khwaja A (2016) Bone disease after kidney transplantation. Clin J Am Soc Nephrol 11:1282–1296

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brandenburg VM, Politt D, Ketteler M, Fassbender WJ, Heussen N, Westenfeld R, Freuding T, Floege J, Ittel TH (2004) Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 77:1566–1571

Article  PubMed  Google Scholar 

McKee H, Ioannidis G, Lau A, Treleaven D, Gangji A, Ribic C, Wong-Pack M, Papaioannou A, Adachi J (2020) Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients. Osteoporos Int 31:973–980

Article  CAS  PubMed  Google Scholar 

Cruz DN, Brickel HM, Wysolmerski JJ, Gundberg CG, Simpson CA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ (2002) Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate. Am J Transplant 2:62–67

Article  CAS  PubMed  Google Scholar 

Conley E, Muth B, Samaniego M, Lotfi M, Voss B, Armbrust M, Pirsch J, Djamali A (2008) Bisphosphonates and bone fractures in long-term kidney transplant recipients. Transplantation 86:231–237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lip A, Warias A, Shamseddin MK, Thomson B, Wijeratne DT (2019) Effect of bisphosphonates on bone health in adult renal transplant patients: beyond the first year posttransplant—a systematic review and meta-analysis. Can J Kidney Health Dis 6:2054358119858014

Article  PubMed  PubMed Central  Google Scholar 

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND (2018) Diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med 168:422–430

Article  PubMed  Google Scholar 

Thongprayoon C, Acharya P, Aeddula NR, Torres-Ortiz A, Bathini T, Sharma K, Ungprasert P, Watthanasuntorn K, Suarez MLG, Salim SA, Kaewput W, Chenbhanich J, Mao MA, Cheungpasitporn W (2019) Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis. Arch Osteoporos 14:35

Article  PubMed  Google Scholar 

Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48:677–692

Article  CAS  PubMed  Google Scholar 

Sayed SA, El Wakeel LM, Elseasi AM, Shawki MA (2023) Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density. Pharmacotherapy 43:904–912

Article  CAS  PubMed  Google Scholar 

Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943–1951

Article  CAS  PubMed  Google Scholar 

Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert R (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. In: Mayo Clinic Proceedings,. vol 12. Elsevier, pp 1493–1501

Hadji P, Papaioannou N, Gielen E, Feudjo Tepie M, Zhang E, Frieling I, Geusens P, Makras P, Resch H, Moller G, Kalouche-Khalil L, Fahrleitner-Pammer A (2015) Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study. Osteoporos Int 26:2479–2489

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harvey NC, Kanis JA, Liu E, Vandenput L, Lorentzon M, Cooper C, McCloskey E, Johansson H (2021) Impact of population-based or targeted BMD interventions on fracture incidence. Osteoporos Int 32:1973–1979

Article  CAS  PubMed  Google Scholar 

Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J (2009) Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health 12:409–418

Article  PubMed  Google Scholar 

Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E (2022) Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Int J Technol Assess Health Care 38:e13

Article  PubMed  Google Scholar 

Kulak CA, Borba VZ, Kulak Junior J, Custodio MR (2014) Bone disease after transplantation: osteoporosis and fractures risk. Arq Bras Endocrinol Metabol 58:484–492

Article  PubMed  Google Scholar 

Tella SH, Gallagher JC (2014) Biological agents in management of osteoporosis. Eur J Clin Pharmacol 70:1291–1301

Article  CAS  PubMed  Google Scholar 

Fasseeh A, Elezbawy B, Korra N, Sedrak A, Kirollos M, Eldessouki R, Eldebeiky M, George M, Seyam A, Abourawash A (2022) POSB205 framework for implementing cost-effectiveness thresholds in Egypt. Value in Health 25:S145

Article  Google Scholar 

Freemantle N, Satram-Hoang S, Tang ET, Kaur P, Macarios D, Siddhanti S, Borenstein J, Kendler DL, Investigators D (2012) Final results of the DAPS (denosumab adherence preference satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int 23:317–326

Article  CAS  PubMed  Google Scholar 

Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C (2002) Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014–3018

Article  PubMed  Google Scholar 

Nikkel LE, Hollenbeak CS, Fox EJ, Uemura T, Ghahramani N (2009) Risk of fractures after renal transplantation in the United States. Transplantation 87:1846–1851

Article  PubMed  Google Scholar 

Abbott KC, Oglesby RJ, Hypolite IO, Kirk AD, Ko CW, Welch PG, Agodoa LY, Duncan WE (2001) Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 11:450–457

Article  CAS  PubMed  Google Scholar 

Naylor KL, Li AH, Lam NN, Hodsman AB, Jamal SA, Garg AX (2013) Fracture risk in kidney transplant recipients: a systematic review. Transplantation 95:1461–1470

Article  PubMed  Google Scholar 

Torregrosa J, Moreno A, Gutierrez A, Vidal S, Oppenheimer F (2003) Alendronate for treatment of renal transplant patients with osteoporosis. In: Transplantation proceedings, Vol 4. Elsevier, pp 1393–1395

Jeon H, Han M, Jeong J, Kim Y, Kwon H, Koo T, Ahn C, Yang J (2013) Impact of vitamin D, bisphosphonate, and combination therapy on bone mineral density in kidney transplant patients. In: Transplantation Proceedings, Vol 8. Elsevier, pp 2963–2967

Marchini M, Trezzi M, Ardini M, Panaro L, Mocka S, Bizzoni P, Rolla D (2022) Denosumab and fracture risk in kidney transplant. G Ital Nefrol 39.

Alfieri C, Binda V, Malvica S, Cresseri D, Campise M, Gandolfo MT, Regalia A, Mattinzoli D, Armelloni S, Favi E, Molinari P, Messa P (2021) Bone effect and safety of one-year denosumab therapy in a cohort of renal transplanted patients: an observational monocentric study. J Clin Med 10:1989

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palmer SC, Strippoli GF, McGregor DO (2005) Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 45:638–649

Article  PubMed  Google Scholar 

Beaudoin C, Jean S, Bessette L, Ste-Marie L-G, Moore L, Brown J (2016) Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis. Osteoporos Int 27:2835–2844

Article  CAS  PubMed  Google Scholar 

Miller PD, Pannacciulli N, Brown JP, Czerwinski E, Nedergaard BS, Bolognese MA, Malouf J, Bone HG, Reginster JY, Singer A, Wang C, Wagman RB, Cummings SR (2016) Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab 101:3163–3170

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Yao M, Xu JH, Shu B, Wang YJ, Cui XJ (2016) Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials. Osteoporos Int 27:1683–1690

Article  PubMed  Google Scholar 

Malluche HH, Monier-Faugere MC, Herberth J (2010) Bone disease after renal transplantation. Nat Rev Nephrol 6:32–40

Article  PubMed